scholarly article | Q13442814 |
P819 | ADS bibcode | 2015PLoSO..1022465A |
P356 | DOI | 10.1371/JOURNAL.PONE.0122465 |
P932 | PMC publication ID | 4388513 |
P698 | PubMed publication ID | 25848763 |
P5875 | ResearchGate publication ID | 276101693 |
P50 | author | Hamad Ali | Q84511648 |
P2093 | author name string | Mohamed Abu-Farha | |
Kazem Behbehani | |||
Ashraf Al Madhoun | |||
Majda K Al-Yatama | |||
P2860 | cites work | The cell surface proteome of human mesenchymal stromal cells | Q21091033 |
Skeletal myosin light chain kinase regulates skeletal myogenesis by phosphorylation of MEF2C | Q24301871 | ||
Expression of early transcription factors Oct-4, Sox-2 and Nanog by porcine umbilical cord (PUC) matrix cells | Q25256954 | ||
Prohibitin 2 regulates the proliferation and lineage-specific differentiation of mouse embryonic stem cells in mitochondria | Q27301072 | ||
Multilineage potential of adult human mesenchymal stem cells | Q27860737 | ||
Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement | Q27861120 | ||
CD105 is important for angiogenesis: evidence and potential applications | Q28207439 | ||
The role of the hyaluronan receptor CD44 in mesenchymal stem cell migration in the extracellular matrix | Q28576237 | ||
Proteomic validation of multifunctional molecules in mesenchymal stem cells derived from human bone marrow, umbilical cord blood and peripheral blood | Q28729931 | ||
Mesenchymal stem cells reside in virtually all post-natal organs and tissues | Q29617740 | ||
Human mesenchymal stem cells modulate B-cell functions | Q29620705 | ||
Mesenchymal stem cell and regenerative medicine: regeneration versus immunomodulatory challenges | Q30009860 | ||
Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing. | Q30157916 | ||
Mesenchymal stem cells in the Wharton's jelly of the human umbilical cord | Q30160386 | ||
Osteoblast mineralization requires beta1 integrin/ICAP-1-dependent fibronectin deposition | Q30502880 | ||
Stem cell proteomes: a profile of human mesenchymal stem cells derived from umbilical cord blood | Q33217620 | ||
A PCR primer bank for quantitative gene expression analysis | Q33447710 | ||
Human mesenchymal stem cells self-renew and differentiate according to a deterministic hierarchy | Q33490119 | ||
Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4+CD25highFOXP3+ regulatory T cells. | Q34007524 | ||
Mesenchymal stem cells: biology and potential clinical uses | Q34034011 | ||
Novel anti-adipogenic activity produced by human fibroblasts. | Q34149741 | ||
The 5'-nucleotidases as regulators of nucleotide and drug metabolism | Q34427241 | ||
The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells | Q34704081 | ||
Proteomics analysis of human obesity reveals the epigenetic factor HDAC4 as a potential target for obesity | Q35005577 | ||
The quantitative proteomes of human-induced pluripotent stem cells and embryonic stem cells | Q35682113 | ||
Mesenchymal stem cells use integrin beta1 not CXC chemokine receptor 4 for myocardial migration and engraftment | Q35942343 | ||
Wharton's jelly-derived mesenchymal stem cells: phenotypic characterization and optimizing their therapeutic potential for clinical applications | Q37007214 | ||
Side-by-side comparison of the biological characteristics of human umbilical cord and adipose tissue-derived mesenchymal stem cells | Q37044121 | ||
Isolation and characterisation of mesenchymal stem cells from different regions of the human umbilical cord | Q37091078 | ||
Getting a grip on Thy-1 signaling | Q37325128 | ||
Proteomic Profiling of Mesenchymal Stem Cell Responses to Mechanical Strain and TGF-beta1. | Q37472305 | ||
Immunological characteristics of human umbilical cord mesenchymal stem cells and the therapeutic effects of their transplantion on hyperglycemia in diabetic rats | Q37496081 | ||
Mesenchymal stem or stromal cells from amnion and umbilical cord tissue and their potential for clinical applications. | Q37512295 | ||
Umbilical cord-derived mesenchymal stem cells: Their advantages and potential clinical utility | Q38207604 | ||
Functional module analysis reveals differential osteogenic and stemness potentials in human mesenchymal stem cells from bone marrow and Wharton's jelly of umbilical cord | Q38506883 | ||
Testosterone enhances cardiomyogenesis in stem cells and recruits the androgen receptor to the MEF2C and HCN4 genes. | Q39164007 | ||
Hedgehog signaling regulates MyoD expression and activity | Q39220900 | ||
Neurogenic properties and a clinical relevance of multipotent stem cells derived from cord blood samples stored in the biobanks. | Q39731781 | ||
Defined serum-free culturing conditions for neural tissue engineering of human cord blood stem cells | Q39991993 | ||
Membrane proteomic analysis of human mesenchymal stromal cells during adipogenesis | Q40053820 | ||
Method to isolate mesenchymal-like cells from Wharton's Jelly of umbilical cord | Q40098194 | ||
Transplantation of placenta-derived mesenchymal stem cells in type 2 diabetes: a pilot study | Q40321403 | ||
Lung resident mesenchymal stem cells isolated from human lung allografts inhibit T cell proliferation via a soluble mediator. | Q40418033 | ||
Immune regulatory properties of multipotent mesenchymal stromal cells: Where do we stand? | Q41807857 | ||
Mesenchymal stem cells: new aspect in cell-based regenerative therapy | Q42852091 | ||
EphB and Ephrin-B interactions mediate human mesenchymal stem cell suppression of activated T-cells. | Q42962199 | ||
The umbilical cord matrix is a better source of mesenchymal stem cells (MSC) than the umbilical cord blood | Q43148158 | ||
Long-term expansion and pluripotent marker array analysis of Wharton's jelly-derived mesenchymal stem cells | Q43709143 | ||
Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation | Q44317237 | ||
Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation | Q44786842 | ||
Directed differentiation of umbilical cord blood stem cells into cortical GABAergic neurons | Q45847272 | ||
Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells | Q46286017 | ||
Mesenchymal stem cell population isolated from the subepithelial layer of umbilical cord tissue | Q46572902 | ||
Effects of mesenchymal stem cells on differentiation, maturation, and function of human monocyte-derived dendritic cells | Q47372947 | ||
In vitro modelling of cortical neurogenesis by sequential induction of human umbilical cord blood stem cells | Q49160861 | ||
Quantification and immunophenotypic characterization of bone marrow and umbilical cord blood mesenchymal stem cells by multicolor flow cytometry. | Q50453265 | ||
Human Wharton's jelly stem cells have unique transcriptome profiles compared to human embryonic stem cells and other mesenchymal stem cells. | Q51812638 | ||
Promising new potential for mesenchymal stem cells derived from human umbilical cord Wharton's jelly: sweat gland cell-like differentiative capacity. | Q51854135 | ||
CD73 and CD29 concurrently mediate the mechanically induced decrease of migratory capacity of mesenchymal stromal cells. | Q52894227 | ||
Changes in chondrogenic phenotype and gene expression profiles associated with the in vitro expansion of human synovium-derived cells. | Q53336410 | ||
Stemness of human Wharton's jelly mesenchymal cells is maintained by floating cultivation. | Q54295907 | ||
Canonical Wnt signaling regulates Foxc1/2 expression in P19 cells. | Q54463714 | ||
Interaction of human mesenchymal stem cells with cells involved in alloantigen-specific immune response favors the differentiation of CD4+ T-cell subsets expressing a regulatory/suppressive phenotype | Q56902900 | ||
Human mesenchymal stromal cells modulate T-cell responses through TNF-α-mediated activation of NF-κB | Q60394821 | ||
Bone marrow- and subcutaneous adipose tissue-derived mesenchymal stem cells: Differences and similarities | Q62633212 | ||
Age-related decline in the osteogenic potential of human bone marrow cells cultured in three-dimensional collagen sponges | Q74357359 | ||
Mesenchymal stem cells distribute to a wide range of tissues following systemic infusion into nonhuman primates | Q78654754 | ||
Biology of stem cells in human umbilical cord stroma: in situ and in vitro surveys | Q79278913 | ||
Isolation, propagation, and characterization of human umbilical cord perivascular cells (HUCPVCs) | Q83001064 | ||
Changes in surface markers of human mesenchymal stem cells during the chondrogenic differentiation and dedifferentiation processes in vitro | Q84325578 | ||
Optimization and scale-up of Wharton's jelly-derived mesenchymal stem cells for clinical applications | Q85110777 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | e0122465 | |
P577 | publication date | 2015-04-07 | |
P1433 | published in | PLOS One | Q564954 |
P1476 | title | Multi-lineage differentiation of human umbilical cord Wharton's Jelly Mesenchymal Stromal Cells mediates changes in the expression profile of stemness markers | |
P478 | volume | 10 |